Marico Q1 FY26 revenue rose 23%; resurfacing August move to lift Plix maker stake to 60%

Marico had reported Q1 FY26 consolidated net profit of Rs 513 crore, up 8.2% year on year, as revenue from operations grew 23.3% to Rs 3,259 crore. India revenue rose 27.2%, while international revenue increased 12.9%. The company had also raised its fully diluted stake in Satiya Nutraceuticals, which owns Plix, to 60%, a move from early August now resurfacing.

— FiledMon, 21 Sept, 2026, 17:04 IST·First seen Mon, 21 Sept, 2026, 17:03 IST·Source Financial Express (via Wayback)

What happened

Marico posted Q1 FY26 profit growth of 8.2% and revenue growth of 23.3%, led by a 27.2% rise in India sales. It raised its stake in Plix maker Satiya

Key facts

  • Q1 FY26 consolidated net profit: Rs 513 crore, up 8.2% YoY
  • Revenue from operations: Rs 3,259 crore, up 23.31% YoY
  • Total income: Rs 3,315 crore
  • India revenue: Rs 2,495 crore, up 27.17% YoY
  • International revenue: Rs 764 crore, up 12.91% YoY
  • India PBT: Rs 469 crore
  • International PBT: Rs 213 crore
  • Total expenses: Rs 2,659 crore
  • Stake in Satiya Nutraceuticals/Plix raised to 60% on a fully diluted basis

Why this matters

Increasing the Plix owner Satiya Nutraceuticals stake to 60% strengthens Marico’s position in wellness and nutrition, indicating greater confidence in scaling the acquired growth platform.

What to watch

  • Sequential volume growth versus price-led revenue growth in India.
  • Gross-margin movement and management commentary on copra, edible oil and packaging inflation.
  • Plix revenue growth, EBITDA trajectory, distribution expansion and integration milestones.
  • Advertising and promotion spend as a share of sales.
  • Rural-demand recovery, monsoon conditions and discretionary wellness-category demand.
  • International-business growth, especially currency and geopolitical effects in key markets.
  • Expand Plix distribution beyond digital channels into modern trade, pharmacies and Marico's general-trade network.
  • Increase brand and innovation spending in health, nutrition and premium personal-care categories.
  • Use selective price increases, pack-size actions and sourcing initiatives to protect gross margins.
  • Pursue further stake consolidation or adjacent health-and-wellness acquisitions if Plix traction remains strong.
  • Highlight India volume growth, rural demand and international-currency impacts in subsequent investor communication.